- Research article
- Open Access
Fibroblast-like synovial cells from normal and inflamed knee joints differently affect the expression of pain-related receptors in sensory neurones: a co-culture study
Arthritis Research & Therapy volume 9, Article number: R6 (2007)
Innervation of the joint with thinly myelinated and unmyelinated sensory nerve fibres is crucial for the occurrence of joint pain. During inflammation in the joint, sensory fibres show changes in the expression of receptors that are important for the activation and sensitization of the neurones and the generation of joint pain. We recently reported that both neurokinin 1 receptors and bradykinin 2 receptors are upregulated in dorsal root ganglion (DRG) neurones (the cell bodies of sensory fibres) in the course of acute and chronic antigen-induced arthritis in the rat. In this study, we begin to address mechanisms of the interaction between fibroblast-like synovial (FLS) cells and sensory neurones by establishing a co-culture system of FLS cells and DRG neurones. The proportion of DRG neurones expressing neurokinin 1 receptor-like immunoreactivity was not altered in the co-culture with FLS cells from normal joints but was significantly upregulated using FLS cells from knee joints of rats with antigen-induced arthritis. The proportion of DRG neurones expressing bradykinin 2 receptors was slightly upregulated in the presence of FLS cells from normal joints but upregulation was more pronounced in DRG neurones co-cultured with FLS cells from acutely inflamed joints. In addition, the expression of the transient receptor potential V1 (TRPV1) receptor, which is involved in inflammation-evoked thermal hyperalgesia, was mainly upregulated by co-culturing DRG neurones with FLS cells from chronically inflamed joints. Upregulation of neurokinin 1 receptors but not of bradykinin 2 and TRPV1 receptors was also observed when only the supernatant of FLS cells from acutely inflamed joint was added to DRG neurones. Addition of indomethacin to co-cultures inhibited the effect of FLS cells from acutely inflamed joints on neurokinin 1 receptor expression, suggesting an important role for prostaglandins. Collectively, these data show that FLS cells are able to induce an upregulation of pain-related receptors in sensory neurones and, thus, they could contribute to the generation of joint pain. Importantly, the influence of FLS cells on DRG neurones is dependent on their state of activity, and soluble factors as well as direct cellular contacts are crucial for their interaction with neurones.
The inflammatory response in organs is produced by numerous inflammatory cell types. These cell types communicate with each other in order to develop an appropriate inflammatory reaction. A large amount of information on the mechanisms of interaction of different inflammatory cells has been obtained from co-culture systems of different cell types, such as T cells and monocytes [1–3], T cells and endothelial cells , T cells and fibroblasts [5–7], monocytes and fibroblasts [8, 9], and macrophages and fibroblasts [10–12]. These data have established the importance of both cell-cell contacts and mediators for the production of the inflammatory activity.
Most tissues are innervated, and nerve fibres play an important role in inflammatory diseases. The activation of nociceptive sensory afferent fibres ('pain fibres') evokes pain, a major symptom of inflammatory diseases . Furthermore, there is growing evidence that primary afferent neurones as well as sympathetic nerve fibres influence the inflammatory process through efferent processes [14–16]. Despite the functional cross-talk between the inflammatory process and neurones, the mechanistic analysis of interactions between non-neuronal inflammatory cells and neurones has not been carried out in great detail. Recently, a first report appeared on the influence of neurones in the central nervous system on T cells and the potential role of neurone-T cell interactions on experimental autoimmune encephalomyelitis .
The somata of primary afferent neurones are located in the dorsal root ganglia (DRG). Similar to the sensory endings, the somata of these neurones express ion channels and receptors that are important for the activation and/or sensitization of these neurones, and they thus seem to represent the total primary afferent neuron in this respect . In addition, the expression of ion channels and receptors in the somata is altered during peripheral inflammation. We recently took DRGs from normal rats and from rats with unilateral acute and chronic antigen-induced arthritis (AIA) in the knee, cultured them for one day and determined which proportion of DRG neurones express receptors for bradykinin (BK) and substance P (neurokinin 1 (NK1) receptors). In lumbar DRGs but not in cervical DRGs from AIA rats we found a pronounced increase in the proportion of neurones exhibiting BK receptors and NK1 receptors . The upregulation of these receptors found in this study and in other studies on inflammation [20, 21] is thought to be involved in the inflammatory pain response because both BK and substance P activate and/or sensitize proportions of primary afferent neurones for mechanical stimuli, which is a mechanism of mechanical hyperalgesia [22–26]. Indeed AIA rats show limping of the inflamed knee and a lowered pain threshold when pressure is applied to the knee . In addition, the transient receptor potential V1 (TRPV1) receptor is an ion channel that is involved in thermal inflammatory hyperalgesia [27–29]. Some studies [30–33], but not others [34, 35], have identified an upregulation of TRPV1 receptors in DRGs in inflammatory models.
We have begun to identify mechanisms that cause the upregulation of BK, NK1 and TRPV1 receptors in DRG neurones. In the present study we co-cultured DRG neurones with fibroblast-like synovial (FLS) cells from either normal knee joints or from acutely or chronically inflamed knee joints from AIA rats. FLS cells are key players in the propagation of joint inflammation and joint destruction during rheumatoid arthritis [36–39] whereas DRG neurones are key players in the development of chronic pain . We addressed three questions. First, is the expression of these receptors in DRG neurones influenced by the presence of FLS cells? Second, do FLS cells from normal and inflamed knee joints exert different effects on receptor expression in DRG neurones? Third, are effects of FLS cells on DRG neurones mediated by soluble mediators (is the supernatant of FLS cells sufficient?) or is the presence of the FLS cells with cellular contacts important? Preliminary results have been reported [40, 41].
Materials and methods
Induction of joint inflammation
In 17 10-week-old female Lewis rats (Charles River, Sulzfeld, Germany), an inflammation was induced in the right knee joint. In the first step the rats received a subcutaneous injection of 500 μg antigen (methylated BSA; Sigma, Deisenhofen, Germany) in 500 μl saline emulsified with 500 μl complete Freund's adjuvant (Sigma; supplemented to 2 mg/ml heat-killed Mycobacterium tuberculosis strain H37RA, Difco, Detroit, MI, USA). In addition, an intraperitoneal injection of 2 × 109 heat-inactivated Bordetella pertussis (Chiron Behring, Marburg, Germany) was performed on the same day. The same immunisation procedure was repeated 7 days later. After a further 14 days, a sterile solution of antigen (methylated BSA), 500 μg in 50 μl saline, was injected into the right knee joint cavity (day 0). Either 3 days (acute AIA) or 20 to 28 days (chronic AIA) after induction of inflammation in the knee joint, the rats were killed by cervical dislocation during ether anaesthesia. In total, 17 untreated rats of the same age and sex were used as normal control animals. All rats were used for the preparation of FLS cells. All procedures complied with the regulations of the Thuringian Commission for Animal Protection.
Preparation of fibroblast-like synovial cells
Explant cultures of FLS cells were prepared from the knee joints of normal rats or from rats 3 days (acute phase) or 20 to 28 days (chronic phase of inflammation) after induction of AIA. The patella and the menisci of the joints with adjacent synovial tissue were separated and cultured in 24-well plates in DMEM (Gibco, BRL, Eggenstein-Leopoldshafen, Germany) containing 20% fetal calf serum (FCS, [Gibco]), 0.1 mg/ml streptomycin (Grünenthal, Aachen, Germany), 100 U/ml penicillin (Jenapharm, Jena, Germany), 2 mmol/l glutamine (Gibco), 10 mM Hepes (Gibco), and 1 mmol/l sodium pyruvate (Gibco) for 7 days at 37°C in a humidified incubator gassed with 5% CO2 in air. During this time, out-growing FLS cells emerged from the tissue. In the first 7 days the medium was replaced daily. After 7 days the residual tissue was removed and 2 days later the cells were transferred to new plates. For this purpose the cells were washed with PBS and incubated for 2 to 4 minutes in PBS containing 0.25% trypsin and 0.02% EDTA (Gibco). Thereafter, the cells were collected, washed with DMEM containing 20% FCS and disseminated. After another 3 to 6 days the cells were transferred into new plates. For the co-culture, cells were used after the third to fifth passage. FLS cells were slowly cooled down with isopropanol to -70°C in DMEM containing 10% dimethylsulfoxide and stored at -192°C over liquid nitrogen until co-culturing.
Primary culture of dorsal root ganglion neurones
Normal male Wistar rats, 60 days old, were sacrificed with a lethal dose of ether. DRGs from all segments of the spinal cord were dissected. Ganglia were incubated at 37°C with 215 U/ml collagenase type II (Paesel and Lorei, Hanau, Germany) dissolved in Ham's F12 medium (Gibco) for 100 minutes. After washing with Ca2+- and Mg2+-free PBS, the ganglia were placed in DMEM (Gibco) containing 10,000 U/ml trypsin (Sigma) for 11 minutes at 37°C. The cells were dispersed by gentle agitation and aspiration with a fire polished Pasteur-pipette. The dispersed cells were collected by centrifugation (500 × g, 5 minutes), washed 3 times in DMEM and centrifuged. The cell pellets were suspended in Ham's F-12 medium containing 10% heat-inactivated horse serum (Gibco), 100 U/ml penicillin (Gibco), 100 μg/ml streptomycin (Gibco), and 100 ng/ml nerve growth factor (NGF; Paesel and Lorei). On average, 200 to 300 DRG neurones were plated on poly-L-lysine- (200 μg/ml) coated glass cover slips (diameter 13 mm) situated in 35/10 mm dishes and maintained for 1 night at 37°C in a humidified incubator gassed with 3.5% CO2 and air. After this overnight setting period, the co-cultures of DRG neurones and the FLS cells were prepared.
Co-culture of FLS cells and DRG neurones
Two days before co-culturing, the FLS cells (from normal rats or from rats with acute or chronic AIA) were thawed and cultured in DMEM containing 20% FCS in a concentration of 2 × 100 cells/well in 24-well dishes. After 2 days, the FLS cells were incubated with 0.25% trypsin (Gibco) and 0.02% EDTA (Sigma) in DMEM for 2 to 4 minutes at 37°C. Thereafter, the cells were washed 3 times with DMEM (containing 100 ng/ml NGF) and added to the glass cover slips with the cultured DRG neurones (see above) in a concentration of 105/ml. The two cell types were co-cultured for 24 hours in DMEM containing 100 ng/ml NGF maintained at 37°C in a humidified incubator gassed with 5% CO2 in air. As a control, either only DRG neurones or only FLS cells were cultured and handled in the same way as the co-cultures. After culturing for 24 hours, all cells on the glass cover slips were fixed and used for immunocytochemical labelling of the NK1, the BK 2 (B2) and the TRPV1 receptors.
In addition, in some experiments, DRG neurones were cultured in medium containing only the supernatant of FLS cells. These FLS cells were isolated from either normal knee joints or knee joints at the acute (day 3) or chonic state (20 to 28 days) of AIA and then cultured for 2 days. The supernatants of these FLS cells were added to the DRG neurones, which were kept for 24 hours at 37°C in a humidified incubator gassed with 5% CO2 in air, and, in addition, 100 ng/ml NGF were administered.
Furthermore, co-cultures of DRG neurones and FLS cells from normal or acutely and chronically inflamed knee joints were made in a medium containing either the cyclooxygenase (COX) inhibitor indomethacin (1 μmol/l; Calbiochem, Bad Soden/Ts, Germany), an antibody against IL-6 (1 μmol/l; BioTrend, Köln, Germany) or IgG from normal rat (1 μmol/l; BioTrend). These co-cultures were kept at 37°C in a humidified incubator gassed with 5% CO2 in air for 24 hours in DMEM containing 100 ng/ml NGF.
Detection of bradykinin 2 receptors
Because a reliable B2 receptor antibody was not available, we used BK-gold conjugates for labelling of B2 receptors. The BK-gold conjugates were prepared as described earlier . In brief, 1 μmol BK (Bachem, Heidelberg, Germany) was dissolved in 500 μl HEPES (20 mmol/l, pH 7.5). This solution was added to 6 nmol sulfo-N-hydroxy-succinimido Nanogold reagent (BioTrend), dissolved in 500 μl ddH2O, and incubated for 1 hour at room temperature. To separate BK-gold conjugates from unbound BK, a membrane centrifugation (Amicon microcon-10 system) was used. The BK-gold conjugate was dissolved in PBS containing 0.1% BSA (Sigma), 0.2 mol/l sucrose (Sigma), 4 μg/ml leupeptin (Sigma) and 10 mmol/l sodium azide (Sigma). This solution was aliquoted and stored at -20°C for a maximum of three months.
The cells were fixed with 2% paraformaldehyde in 0.1 mol phosphate buffer (pH 7.2) for 30 minutes. After washing with PBS (20 mmol/l, pH 7.4), the cells were pre-treated with 50 mmol/l glycine in PBS and, thereafter, with 5% BSA and 0.1% gelatine in PBS for 30 minutes. Then the cells were washed with 0.1% acetylated BSA (BSA-C; BioTrend) and incubated overnight with 0.3 nmol/ml BK-gold in PBS containing 0.1% BSA-C, bacitracin (40 μg/ml; Sigma), leupeptin (4 μg/ml; Sigma) and chymostatin (2 μg/ml; Sigma) at 4°C in a moist chamber. Following washing with PBS plus 0.1% BSA-C and, thereafter, with PBS to remove unbound BK-gold, cells were postfixed with 2% glutaraldehyde in PBS for 10 minutes. After extensive washing with PBS and ddH2O, the gold particles were intensified with silver enhancer (R-Gent, pH 5.5; BioTrend) for 15 minutes at 22°C. The reaction was stopped by washing in ddH2O. To examine whether the binding was related to B2 receptors, 3 nmol/ml BK-gold was incubated in parallel control dishes in the presence of 1 μmol/ml D-Arg [Hyp3-Thi5,8-D-Phe7]-BK (Sigma), a BK analogue that specifically binds to the B2 receptor. This analogue produces a complete displacement of BK-gold.
Immunocytochemical labelling of NK1 and TRPV1 receptors
The cover slips were transferred to 2% paraformaldehyde in 0.1 mol/l phosphate buffer (pH 7.2) plus 0.3% Triton X-100 (TX-100) for 30 minutes. After washing with PBS plus 0.3% Triton X-100 (PBS TX-100), cells were incubated with 50 mmol/l glycine in PBS TX-100 and, thereafter, with 5% BSA and 0.1% gelatine in PBS TX-100 for 30 minutes. Then the cells were washed with PBS TX-100 and incubated for 30 minutes in PBS TX-100 containing 2% normal goat serum (BioTrend). Thereafter, the cells were washed with PBS TX-100 containing 0.1% BSA-C and incubated overnight with an anti-NK1 antibody diluted 1:100 in PBS TX-100 plus 1% normal goat serum (the antibody was raised in rabbit against amino acids 393 to 407 of the rat NK1 receptor; Sigma) or with an antibody to the TRPV1 receptor (VR11-A, 1:75; Alpha Diagnostics, San Antonio, USA) at 4°C in a moist chamber. The cover slips were extensively rinsed in PBS TX-100 plus 0.1% BSA-C and, thereafter, in PBS TX-100. After washing, the cells were incubated for 4 hours at 20°C with a gold-labelled (10 nm) anti-rabbit antibody developed in goat (BioTrend), diluted 1:100 in PBS TX-100 plus 1% normal goat serum. After washing with PBS TX-100, PBS and ddH2O, the gold particles were intensified with silver enhancer (R-Gent, pH 5.5) for 20 minutes at 21°C. The reaction was stopped by washing in ddH2O. To test for unspecificity of the detection system, cells were incubated only with the secondary antibody. In these cultures no cells were labelled.
Double-labelling with an antibody against neurone-specific enolase
To identify the neurones in the cultures, double-staining with an anti-neurone-specific enolase (NSE) antibody was used in all experiments in which B2, NK1, and TRPV1 receptor labelling was performed. After washing with PBS, the cover-slips were incubated overnight at 4°C with the anti-NSE-antibody (Sigma) developed in rabbit (diluted 1:100). Then the cover-slips were incubated with a goat anti-rabbit antibody labelled with Cy3 (diluted 1:200; Jackson ImmunoResearch, Cambridgeshire, UK) for 2 hours. After washing with PBS, all cover slips were embedded in Vectashield (Vector, Burlingame, England). In control experiments in which the primary antibody (anti-NSE) was omitted, no fluorescence signal was detectable.
Prostaglandin E2and IL-6 measurement in the supernatant of the cultures
The supernatants of cultured DRG neurones, cultured FLS cells and co-cultures of DRG neurones and FLS cells (from normal and acutely or chronically inflamed joints) were analysed for the production of prostaglandin E2 (PGE2) and IL-6. The samples were stored at -20°C until analysis. For each substance, four independent cultures were used. All samples were measured twice. The supernatants were analysed with commercial ELISA kits for PGE2 (Cayman Chemicals, Ann Arbor, Michigan, USA) and for rat IL-6 (OptEIA; BD Biosciences, Heidelberg, Germany).
From each cover slip, 100 structurally intact and NSE-labelled neurones were examined with a light microscope (Axioplan 2, Zeiss, Germany) coupled to a CCD video camera and an image analysing system (KS 300, Zeiss, Germany). The mean area and mean grey value were determined for each neuronal soma. To take into account differences in the basal grey values on each coated cover slip, a relative grey value of each neurone was calculated by dividing the mean grey value of the neurone by the grey value of the cover slip background. For an unbiased discrimination of cells with or without positive labelling with the antibodies against NK1 and TRPV1 or BK-gold, neurones were considered positive if their relative grey value was above that of neurones from the control incubations, which were not treated with the antibodies against NK1 or TRPV1 receptors. In experiments with BK-gold labelling, neurones were considered positive if their relative grey value was above that of neurones from the displacement control incubations with a BK analogue that specifically binds to the B2 receptor. This value was 0.16; thus, all neurones with grey density >0.16 were considered as positive for the antibodies or B2 receptor BK-gold binding. Proportions of labelled neurones are expressed as the mean ± standard deviation. For statistical analysis we used χ2-tests taking into account multiple comparisons. Significant differences were acknowledged if p < 0.05.
As a first step we characterized the morphology of FLS cells and DRG neurones in the co-culture system. The FLS cells formed a flat layer composed mainly of triangular NSE-negative cells (Figure 1a). After the setting period, DRG neurones that showed strong NSE-like immunoreactivity (IR) were dispersed as single cells or small cell clusters on the FLS cell layer (Figure 1b, neurones are labelled with stars). Only very few FLS cells (maximum of 1%) showed some NSE-like IR and, therefore, the antibody against NSE is a good tool to differentiate between neurones and FLS cells. The neurones had round perikarya of varying sizes and thin neurites spanning over and along FLS cells (Figure 1b–d).
DRG neurones are characterized by the size of their cell body and exhibit a typical size distribution with most cells in the small- and medium-sized range (which give rise to unmyelinated and thin myelinated axons) and fewer cells in the large-sized range (which give rise to thick myelinated axons). To compare the size distribution of DRG neurones in different cultures, we determined the diameter of neurones in the DRG mono-culture and in the co-cultures with FLS cells from acutely and chronically inflamed knee joints. The size distribution of neurones was similar under all culture conditions, indicating that the DRG cell samples were comparable (Figure 2). The morphology of FLS cells was also similar in mono-cultures and in co-cultures with DRG neurones.
Expression of NK1, B2, and TRPV1 receptor-like IR in DRG neurones after co-culture with FLS cells
As a first approach we tested whether the presence of FLS cells from normal, acutely or chronically inflamed knee joints influences receptor expression in DRG neurones taken from normal rats. DRG neurones were fixed 24 hours after co-culturing and receptor expression was determined in NSE-labelled DRG neurones.
Neurokinin 1 receptor-like immunoreactivity
In the standard mono-culture of DRG neurones from adult normal rats, only a small proportion of neurones showed NK1 receptor-like IR, similar to previously reported studies [19, 43]. On average, 8.8 ± 2.0% of the DRG neurones (4 cultures) were labelled with the anti-NK1 receptor antibody (Figure 3c, first bar). When DRG neurones were co-cultured with FLS cells isolated from the knee joint of normal adult rats, a similar proportion of DRG neurones (8.4 ± 2.1%, 5 cultures) showed NK1 receptor-like IR (Figure 3c, second bar). However, in co-cultures of DRG neurones from normal rats and FLS cells from the inflamed knee of AIA rats, the proportion of neurones expressing NK1 receptor-like IR was significantly higher (Figure 3c, third and fourth bar). Figure 3a,b displays a cover slip with a co-culture of DRG neurones and FLS cells isolated from acutely inflamed knee joints (3 days of AIA). The dark cell in Figure 3a (see arrow) is labelled for NK1 receptor-like IR, and Figure 3b shows that this cell is also NSE-positive. Counting of double-labelled neurones showed that 31.3 ± 6.7% of the DRG neurones expressed NK1 receptor-like IR after co-culture with FLS cells isolated from knee joints of rats at 3 days of AIA (4 cultures), whereas 27.0 ± 2.9% of the DRG neurones were labelled with the anti-NK1 receptor antibody after co-culture with FLS cells isolated from the knee joint of rats at 21 to 28 days of AIA (chronic AIA, 4 cultures). At both time points, NK1 receptor expression was increased significantly compared to the mono-culture of DRG neurones and the DRG co-culture with FLS cells from normal knee joints. Black columns in Figure 2a show the proportions of neurones exhibiting NK1 receptor-like IR. Thus, FLS cells isolated from both acutely and chronically inflamed knee joints induced an upregulation of the NK1 receptor in DRG neurones from normal rats whereas a co-culture with FLS cells from normal knee joints did not. FLS cells themselves did not show NK1 receptor-like IR.
Bradykinin 2 receptor-like labelling
Because a BK analogue that specifically binds to the B2 receptor completely displaced the BK-gold particle (see Materials and methods), we conclude that BK-gold binds only to B2 receptors in this experimental approach. In the standard mono-culture of DRG neurones from normal adult rats, 36.8 ± 3.4% of all DRG neurones (5 cultures) showed B2 receptor-like labelling (Figure 4c, first bar), which is in the same range as in previous studies [19, 42, 44, 45]. When DRG neurones and FLS cells isolated from knee joints of normal adult rats were co-cultured, on average, 53.5 ± 7.1% of the DRG neurones (4 cultures) were labelled for B2 receptors. Thus, in contrast with NK1 receptor expression, FLS cells from normal knee joints caused a significant up-regulation of the proportion of DRG neurones exhibiting B2 receptor-like labelling (Figure 4c, second bar). Compared to co-cultures of DRG neurones and FLS cells from normal joints, a significantly higher proportion of DRG neurones (on average, 69.5 ± 9.9% of the DRG neurones, 4 cultures) showed B2 receptor expression when FLS cells from acutely inflamed knee joints were used for co-culture (Figure 4c, third bar). In co-cultures of DRG neurones and FLS cells from chronically inflamed joints, 56.5 ± 16% of the DRG neurones were labelled for B2 receptors (8 cultures, not significantly different from co-cultures of DRG neurones and FLS cells from normal knee joints). Figure 4a,b displays a cover slip with a co-culture of DRG neurones and FLS cells isolated from knee joint from rats at the acute AIA stage. The size distribution of labelled neurones is shown in Figure 2b. FLS cells did not exhibit B2 receptor labelling.
TRPV1 receptor-like immunoreactivity
In 13 DRG mono-cultures from normal adult rats, 21.0 ± 5.1% of the neurones showed TRPV1 receptor-like IR (Figure 5c, first bar). In 7 co-cultures of DRG neurones and FLS cells isolated from normal knee joints, on average, 28.1 ± 11.3% of the DRG neurones showed TRPV1 receptor-like IR (Figure 5c, second bar), and this proportion was not different from that in DRG neurones in mono-cultures. Co-cultures of DRG neurones with FLS cells from knee joints of AIA rats yielded higher proportions of neurones exhibiting TRPV1 receptor-like IR. After co-culture with FLS cells from acutely inflamed knee joints, 34.5 ± 5.5% of DRG neurones were immunopositive for the TRPV1 receptor (4 cultures), and after co-culture with FLS cells from chronically inflamed knee joints, 50.1 ± 6.8% of the DRG neurones were immunopositive (7 cultures; Figure 5c, third and fourth bar). These proportions of immunopositive neurones were significantly higher than the proportion of those in the DRG mono-culture but only the latter value (co-cultures with FLS cells from chronically inflamed joints) was significantly higher than the proportion of immunopositive neurones in the co-culture with FLS cells from normal joints. Figure 5a,b displays a cover slip with a co-culture of DRG neurones and FLS cells isolated from acutely inflamed knee joints. Figure 2c shows the size distribution of labelled neurones. FLS cells did not show TRPV1 receptor-like IR.
Influence of soluble FLS cell mediators on the expression of NK1, B2, and TRPV1 receptors
In a second approach, we tested whether soluble mediators are responsible for the up-regulation of NK1, B2, and TRPV1 receptors that is observed in co-culture with FLS cells. We cultured DRG neurones and added only the supernatant from cultured FLS cells sampled from normal and inflamed knee joints. The results are displayed in Figure 6.
Only NK1 receptor-like IR was changed by addition of supernatant and this effect was dependent on the source of the supernatant (Figure 6a). The supernatant from FLS cells from normal knee joints did not change the proportion of neurones showing NK1 receptor-like IR. In 4 cultures, 15.4 ± 2.6% of the neurones were immunopositive, versus 15.3 ± 2.6% of the neurones in 5 control cultures with normal medium. After application of the supernatant of FLS cells from acute AIA joints, the proportion of DRG neurones with NK1 receptor-like IR significantly increased to 48.2 ± 4.7% (4 cultures). Such an effect was not seen when supernatant from FLS cells from chronically inflamed knee joints was added to the neurones. In this case, only 12.0 ± 4.0% (3 cultures) of the neurones showed NK1 receptor-like IR. By contrast, none of the supernatants influenced the proportion of DRG neurones showing B2 receptor labelling (Figure 6b, each value is from three to five cultures) and TRPV1 receptor labelling (Figure 6c, each value is from three cultures).
Because we previously found that the expression of NK1 receptor-like IR in DRG neurones is upregulated by long-term addition of either PGE2  or IL-6  to the culture medium, we measured the concentration of PGE2 and IL-6 in the supernatants from different cultures, and we tested whether interference of PGE2 and IL-6 would reduce the effect of FLS cells on NK1 receptor expression in DRG neurones. While PGE2 and IL-6 were below the detection level in the supernatants from DRG mono-cultures, the supernatants of FLS cells from normal joints contained both PGE2 and IL-6 (Table 1). The concentrations of both mediators were higher in supernatants of FLS cells from acutely inflamed joints. The concentration of PGE2 tended to be even higher in supernatants of FLS cells plus DRG neurones. The PGE2 concentration was also measured in the supernatant from chronically inflamed joints. It was even more elevated than in the supernatant of FLS cells from acutely inflamed joints but was not further enhanced by addition of DRG neurones (Table 1). IL-6 was not found to be elevated in the chronic stage of AIA  and was, therefore, not determined in the present study.
The results of different treatments to interfere with PGE2 and IL-6 are shown in Figure 7. The expression of NK1 receptor-like IR was analysed 24 hours after co-culturing. In co-cultures of DRG neurones and FLS cells from acutely and chronically inflamed knee joints without additional treatment, we found the typical upregulation of NK1 receptor-like IR (first three columns, 4 cultures each). This was different when the COX inhibitor indomethacin (1 μmol/l) was added to the medium (columns 4 to 6). After addition of indomethacin, only few DRG neurones co-cultured with FLS cells from normal joints showed NK1 receptor-like IR, and the upregulation in the presence of FLS cells from acutely inflamed knees was prevented because, under these conditions, only 8.9 ± 1.7% of the DRG neurones showed NK1 receptor-like IR (black column). This proportion is significantly lower than the proportion of NK1 receptor-immunopositive neurones from co-cultures with FLS cells from acutely inflamed knee joints but without indomethacin. However, indomethacin did not prevent upregulation of NK1 receptor-like IR in co-cultures with FLS cells from chronically inflamed knee joints, consistent with the finding that the supernatant from FLS cells from chronically inflamed knee joints did not induce upregulation of NK1 receptor-like IR. By contrast, neither the addition of an antibody to IL-6 (1 μmol/l) nor addition of normal rat IgG (1 μmol/l) prevented the upregulation of NK1 receptor-like IR in the presence of FLS cells from acutely and chronically inflamed knee joints (Figure 7, each column shows the data from 4 co-cultures). These data suggest that a COX product plays an important role in the upregulation of NK1 receptor-like IR in the acute stage of inflammation but not in the chronic one.
The present study shows that FLS cells from the knee joint influence the expression of pain-related receptors in DRG neurones. The expression of NK1 receptors was affected only by co-culture with FLS cells from inflamed knee joints. By contrast, B2 receptors were upregulated by FLS cells from normal knee joints, and this effect was more pronounced in the co-culture with FLS cells from acutely inflamed joints. The expression of TRPV1 receptors was slightly upregulated by FLS cells from normal joints, but a significant upregulation was found only in the presence of FLS cells from inflamed joints, with the strongest effects after co-culture with FLS cells from chronically inflamed joints. The upregulation of NK1 receptor-like IR by FLS cells from acutely inflamed joints was mimicked by the supernatant of FLS cells from acutely inflamed joints, but the expression of neither B2 nor TRPV1 receptors was influenced by supernatants from FLS cells from normal, acutely or chronically inflamed knee joints. Although FLS cells from both acutely and chronically inflamed joints produced elevated levels of PGE2, only the upregulation of NK1 receptor-like IR by FLS cells from acutely inflamed joints was prevented by indomethacin, suggesting that prostaglandins and/or other COX products are relevant mediators for receptor regulation in acute arthritis but not in chronic arthritis.
Initially, it was important to establish optimal conditions for co-culturing FLS cells and DRG neurones. We chose a DMEM medium that is routinely used for FLS cells. However, we did omit FCS in order to avoid uncontrollable concentrations of additives, such as growth factors, and added nerve growth factor to support the development of neurites. Although the major FLS cell type was morphologically different from DRG neurones, some cells could not be identified. We therefore used an antibody to NSE in the mono-cultures and the co-cultures and found that this antibody reliably labels neurones but does not label FLS cells. According to the literature, the anti-NSE antibody labels about 95% of the neurones . We therefore used this antibody for double-labelling in all experiments.
Several parameters indicate that the co-culture conditions are suitable for the survival of neurones. First, neuronal perikarya in the co-culture had a similar size distribution as perikarya in DRG mono-cultures. Second, labelling for neuronal receptors yielded similar values as for neurones in DRG mono-cultures. In the absence of an inflammatory stimulus, about 10% of DRG neurones show NK1 receptor-like IR in the co-culture system as well as DRG mono-cultures, and about 40% of the DRG neurones exhibit BK-gold binding in the co-culture system and DRG mono-cultures. Only the expression of the TRPV1 receptor was less widespread than expected. From immunohistological staining of DRG sections one would expect between 30% and 40% of the neurones to be immunopositive [49, 50] but only 21% of the DRG neurones were immunopositive in mono-culture, and 28% after co-culture with FLS cells from normal knee joints. This may be due to a decrease in receptor expression over time. In fact, in DRG mono-cultures of 1 day, between 30% and 40% of the neurones show an increase in [Ca2+]i after bath application of capsaicin, an agonist of the TRPV1 receptor, indicating a higher proportion of TRPV1 receptor-positive neurones (unpublished observations), and this is in line with the literature [51, 52].
A major finding of this study is that receptor expression in DRG neurones in the co-culture system was influenced similarly to that under conditions of in vivo inflammation. In lumbar DRGs from rats with acute AIA in the knee joint, up to 50% of the DRG neurones showed NK1 receptor expression, and about 80% of the DRG neurones showed BK-gold binding . Thus, receptor upregulation in the co-culture system reached almost the same level as in the course of AIA in vivo. In the case of the TRPV1 receptor, the proportion of positive neurones increased by about 10% in the positive studies (see Introduction), and TRPV1 receptor upregulation in the present co-culture system was in the same range. These data show that the co-culture system of FLS cells and DRG neurones is a powerful tool for the study of interactions between inflammatory processes and primary afferent neurones.
The present data provide the important novel finding that most of the changes in the receptor expression occur only when FLS cells are present, whereas the supernatant from FLS cells was not sufficient to induce changes in receptor expression, except for the upregulation of NK1 receptor expression (see below). This finding matches our previous observation that only the expression of the NK1 receptor could be manipulated by adding inflammatory compounds to the culture medium  whereas the expression of BK receptors was never changed by adding inflammatory compounds (unpublished observations). The data showing receptor regulation only in the presence of non-neuronal cells such as FLS cells could be a milestone in the study of mechanisms that induce changes in neurones in the course of inflammation. The most likely explanation for the positive influence of FLS cells on neurones is that FLS cells provide signals to neurones that are absent in the supernatant. Either direct cellular contacts are required to mediate the effect of FLS cells on neurones, or FLS cells create a local milieu that is not maintained in the supernatant, or both mechanisms may be at work.
Notably, FLS cells from normal, acutely and chronically inflamed joints had different effects on receptor expression in DRG neurones. FLS cells from normal knee joints induced a small upregulation of BK and TRPV1 receptors, suggesting that the basal expression of these receptors is partly dependent on extraneuronal factors. It is possible that explant cultures of FLS cells from normal knee joints do not provide an entirely physiological milieu and, therefore, it is difficult to make firm conclusions about whether FLS cells exert trophic influences on neurones under non-inflammatory conditions. However, comparison of the effects of FLS cells from normal and inflamed joints shows the potential of FLS cells to influence neurones under inflammatory conditions. The finding that BK receptors were mainly upregulated by FLS cells from acutely inflamed joints, whereas TRPV1 receptors were mainly increased by FLS cells from chronically inflamed joints, shows the potential of this approach to define mechanisms involved in neuronal receptor regulation at different stages of inflammation.
While the expression of BK and TRPV1 receptors was entirely dependent on the presence of FLS cells, the expression of NK1 receptors was also influenced by the supernatant of FLS cells from acutely inflamed knee joints, suggesting that soluble factors play an important role. There is some evidence that prostaglandins are involved. First, PGE2 production is increased in FLS cells from inflamed knee joints (see also [38, 39]). Second, addition of PGE2 to the culture medium of DRG neurones enhances the proportion of neurones with NK1 receptor-like IR through activation of adenylate cyclase and protein kinase A . Third, the effect of FLS cells from acutely inflamed joints on NK1 receptor expression in DRG neurones was blocked by application of the COX inhibitor indomethacin to the co-culture. Together, these data indicate a crucial role of prostaglandins in NK1 receptor upregulation at the acute stage of inflammation.
However, this explanation is not applicable to the effect of FLS cells from chronically inflamed knee joints on NK1 receptor expression. Unlike the presence of FLS cells from chronically inflamed joints, the supernatant of FLS cells from chronically inflamed joints did not cause NK1 receptor upregulation, nor was upregulation reduced by indomethacin. These data suggest that cellular interactions are important for this effect. It is unclear why the supernatant of FLS cells from chronically inflamed joints did not induce NK1 receptor upregulation. One possibility could be that FLS cells from chronically inflamed joints secrete, in addition to PGE2, other mediators that counteract the PGE2 effect. For example, the PGE2 effect on NK1 receptor expression can be blocked by somatostatin, which inhibits adenylate cyclase .
The present study addresses the regulation of receptors in DRG neurones that are involved in the generation of inflammatory pain and hyperalgesia. Substance P sensitises joint afferents for mechanical stimuli, thus inducing mechanical hyperalgesia [24, 25]. BK activates and sensitizes primary afferents for mechanical and chemical stimuli [13, 22, 23, 26] and is, therefore, an important pain mediator. The TRPV1 receptor is an ion channel that is involved in thermal inflammatory hyperalgesia [27–29]. All of these receptors are upregulated at some stage of inflammation. In the present study, we have established for the first time a co-culture system of FLS cells and DRG neurones that enables the investigation of mechanisms of interaction between cells contributing to joint pathology and neurones involved in pain and neurogenic mechanisms of inflammation. We provide evidence that three different pain-related receptors in DRG neurones are differently regulated by FLS cells and mediators from FLS cells. While extracellular soluble mediators from FLS cells from acutely inflamed knee joints are sufficient for the upregulation of NK1 receptors, the presence and most likely direct cellular contacts between FLS cells and sensory neurones are required for the upregulation of B2 and TRPV1 receptors. Importantly, the state of activity of FLS cells is crucial for their impact on neurones and, therefore, they are likely to play a pivotal role in the generation of inflammatory pain.
bovine serum albumin
acetylated bovine serum albumin
Dulbecco's modified Eagle's medium
dorsal root ganglion
fetal calf serum
nerve growth factor
transient receptor potential V1
Burger D, Dayer JM: The role of human T-lymphocyte-monocyte contact in inflammation and tissue destuction. Arthritis Res. 2002, 4 (Suppl 3): S169-S176. 10.1186/ar558.
Lacraz S, Isler P, Vey E, Welgus HG, Dayer JM: Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expression. J Biol Chem. 1994, 269: 22027-22033.
Li JM, Isler P, Dayer JM, Burger D: Contact-dependent stimulation of monocytic cells and neutrophils by stimulated human T-cell clones. Immunology. 1995, 84: 571-576.
Lou J, Dayer JM, Grau GE, Burger D: Direct cell/cell contact with stimulated T lymphocytes induces the expression of cell adhesion molecules and cytokines by human brain microvascular endothelial cells. Eur J Immunol. 1996, 26: 3107-3113.
Bombara MP, Webb DL, Conrad P, Marlor CW, Sarr T, Ranges GE, Aun TM, Greve JM, Blue ML: Cell contact between T cells and synovial fibroblasts causes induction of adhesion molecules and cytokines. J Leukoc Biol. 1993, 54: 399-406.
Burger D, Rezzonico R, Li JM, Modoux X, Pierce RA, Welgus HG, Dayer JM: Imbalance between interstitial collagenase and tissue inhibitor of metalloproteinases 1 in synoviocytes and fibroblasts upon direct contact with stimulated T lymphocytes: involvement of membrane-associated cytokines. Arthritis Rheum. 1998, 41: 1748-1759. 10.1002/1529-0131(199810)41:10<1748::AID-ART7>3.0.CO;2-3.
Yamamura Y, Gupta R, Morita Y, He X, Pai R, Endres J, Freiberg A, Chung K, Fox DA: Effector function of resting T cells: activation of synovial fibroblasts. J Immunol. 2001, 166: 2270-2275.
Blue ML, Conrad P, Webb DL, Sarr T, Macaro M: Interacting monocytes and synoviocytes induce adhesion molecules by a cytokine-regulated process. Lymphokine Cytokine Res. 1993, 12: 213-218.
Chomarat P, Rissoan MC, Pin JJ, Banchereau J, Miossec P: Contribution of IL-1, CD14, and CD13 in the increased IL-6 production induced by in vitro monocyte-synoviocyte interactions. J Immunol. 1995, 155: 3645-3652.
Lind M, Trindade MC, Yaszay B, Goodman SB, Smith RL: Effects of particulate debris on macrophage-dependent fibroblast stimulation in coculture. J Bone Joint Surg Br. 1998, 80: 924-930. 10.1302/0301-620X.80B5.8710.
Song E, Ouyang N, Horbelt M, Antus B, Wang M, Exton MS: Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cell Immunol. 2000, 204: 19-28. 10.1006/cimm.2000.1687.
Steinhauser ML, Kunkel SL, Hogaboam CM, Evanoff H, Strieter RM, Lukacs NW: Macrophage/fibroblast coculture induces macrophage inflammatory protein-1 alpha production mediated by intercellular adhesion molecule-1 and oxygen radicals. J Leukoc Biol. 1998, 64: 636-641.
Schaible HG, Richter F: Pathophysiology of pain. Langenbecks Arch Surg. 2004, 389: 237-243. 10.1007/s00423-004-0468-9.
Jänig W, Levine JD: Autonomic-endocrine-immune interactions in acute and chronic pain. Wall and Melzacks's Textbook of Pain. Edited by: McMahon SB, Koltzenburg M. 2005, London: Elsevier, 205-218.
Schaible HG, Del Rosso A, Matucci-Cerinic M: Neurogenic aspects of inflammation. Rheum Dis Clin North Am. 2005, 31: 77-101. 10.1016/j.rdc.2004.09.004.
Straub RH, Cutolo M: Involvement of the hypothalamic-pituitary-adrenal/gonadal axis and the peripheral nervous system in rheumatoid arthritis: viewpoint based on a systemic pathogenetic role. Arthritis Rheum. 2001, 44: 493-507. 10.1002/1529-0131(200103)44:3<493::AID-ANR95>3.0.CO;2-U.
Liu Y, Teige I, Birnir B, Issazadeh-Navikas S: Neuron-mediated generation of regulatory T cells from encephalitogenic T cells suppresses EAE. Nature Med. 2006, 12: 518-525. 10.1038/nm1402.
Marchand F, Perretti M, McMahon SB: Role of the immune system in chronic pain. Nat Rev Neurosci. 2005, 6: 521-532. 10.1038/nrn1700.
von Banchet SG, Petrow PK, Bräuer R, Schaible HG: Monoarticular antigen-induced arthritis leads to pronounced bilateral upregulation of the expression of neurokinin1 and bradykinin 2 receptors in dorsal root ganglion neurones of rats. Arthritis Res. 2000, 2: 424-427. 10.1186/ar121.
Banik RK, Kozaki Y, Sato J, Gera L, Mizumura K: B2 receptor-mediated enhanced bradykinin sensitivity of rat cutaneous C-fiber nociceptors during persistent inflammation. J Neurophysiol. 2001, 86: 2727-2735.
Carlton SM, Coggeshall RE: Inflammation-induced up-regulation of neurokinin1-receptors in rat glabrous skin. Neurosci Lett. 2002, 326: 29-36. 10.1016/S0304-3940(02)00299-9.
Dray A: Tasting the inflammatory soup: the role of peripheral neurones. Pain Rev. 1994, 1: 153-171.
Dray A, Perkins M: Bradykinin and inflammatory pain. Trends Neurosci. 1993, 16: 99-104. 10.1016/0166-2236(93)90133-7.
Heppelmann B, Pawlak M: Sensitisation of articular afferents in normal and inflamed knee joints by substance P in the rat. Neurosci Lett. 1997, 223: 97-100. 10.1016/S0304-3940(97)13408-5.
Herbert MK, Schmidt RF: Sensitisation of group III articular afferents to mechanical stimuli by substance P. Inflamm Res. 2001, 50: 275-282. 10.1007/s000110050754.
Liang YF, Haake B, Reeh PW: Sustained sensitization and recruitment of cutaneous nociceptors by bradykinin and a novel theory of its excitatory action. J Physiol. 2001, 532: 229-239. 10.1111/j.1469-7793.2001.0229g.x.
Caterina MJ, Leffler A, Malmberg AB, Martin WJ, Trafton J, Petersen-Zeitz KR, Koltzenburg M, Basbaum AI, Julius D: Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science. 2000, 288: 306-313. 10.1126/science.288.5464.306.
Davis JB, Gray J, Gunthorpe MJ, Hatcher JP, Davey PT, Overend P, Harries MH, Latcham J, Clapham C, Atkinson K, et al: Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature. 2000, 405: 183-187. 10.1038/35012076.
Papapoutian A, Peier AM, Story GM, Viswanath V: ThermoTRP channels and beyond: mechanisms of temperature sensation. Nat Rev Neurosci. 2003, 4: 529-539. 10.1038/nrn1141.
Amaya F, Oh-Hashi K, Naruse Y, Iijima N, Ueda M, Shimosato G, Tominaga Y, Tanaka Y, Tanaka M: Local inflammation increases vanilloid receptor 1 expression within distinct subgroups of DRG neurons. Brain Res. 2003, 963: 190-196. 10.1016/S0006-8993(02)03972-0.
Bron R, Klesse LJ, Shah K, Parada LF, Winter J: Activation of Ras is necessary and sufficient for upregulation of vanilloid receptor type 1 in sensory neurons by neurotrophic factors. Mol Cell Neurosci. 2003, 22: 118-132. 10.1016/S1044-7431(02)00022-2.
Carlton SM, Coggeshall RE: Peripheral capsaicin receptors increase in the inflamed rat hindpaw: a possible mechanism for peripheral sensitization. Neurosci Lett. 2001, 310: 53-56. 10.1016/S0304-3940(01)02093-6.
Ji RR, Samad TA, Jin SX, Schmoll R, Woolf CJ: p38MAPK activation by NGF in primary sensory neurons after inflammation increases TRPV1 levels and maintains heat hyperalgesia. Neuron. 2002, 36: 57-68. 10.1016/S0896-6273(02)00908-X.
Bär KJ, Schaible HG, Bräuer R, Halbhuber KJ, von Banchet SG: The proportion of TRPV1 protein-positive lumbar DRG neurones does not increase in the course of acute and chronic antigen-induced arthritis in the knee joint of the rat. Neurosci Lett. 2004, 361: 172-175. 10.1016/j.neulet.2003.12.034.
Zhou Y, Li GD, Zhao ZQ: State-dependent phosphorylation of ε-isozyme of protein kinase C in adult rat dorsal root ganglia after inflammation and nerve injury. J Neurochem. 2003, 85: 571-580.
Edwards JC: Fibroblast biology. Development and differentiation of synovial fibroblasts in arthritis. Arthritis Res. 2000, 2: 344-347. 10.1186/ar110.
Konttinnen YT, Li TF, Hukkanen M, Ma J, Xu JW, Virtanen I: Fibroblast biology. Signals targeting the synovial fibroblast in arthritis. Arthritis Res. 2000, 2: 348-355. 10.1186/ar111.
Mor A, Abramson SB, Pillinger MH: The fibroblast-like synovial cell in rheumatoid arthritis: a key player in inflammation and joint destruction. Clin Immunol. 2005, 115: 118-128. 10.1016/j.clim.2004.12.009.
Ritchlin C: Fibroblast biology. Effector signals released by the synovial fibroblast in arthritis. Arthritis Res. 2000, 2: 356-360. 10.1186/ar112.
Segond von Banchet G, Pilecki J, Hückel M, Bräuer R, Schaible H-G: Studies on receptor expression in DRG neurones in a co-culture of DRG neurones and synoviocytes. Eur J Physiol. 2003, 445: P16-1.
Segond von Banchet G, Pilecki J, Hückel M, Bräuer R, Schaible H-G: Synoviocytes from the rat knee joint influences receptor expression in dorsal root ganglion neurones in a co-culture system. Brain Behav Immunity. 2004, 18-
Segond von Banchet G, Petersen M, Heppelmann B: Bradykinin receptors at cultured rat dorsal root ganglion cells: influence of length of time in culture. Neuroscience. 1996, 75: 1211-1218. 10.1016/0306-4522(96)00346-6.
Segond von Banchet G, Scholze A, Schaible HG: Prostaglandin E2 increases the expression of the neurokinin1 receptor in adult sensory neurones in culture – a novel role of prostaglandins. Br J Pharmacol. 2003, 139: 672-680. 10.1038/sj.bjp.0705278.
Petersen M, Eckert AS, Segond von Banchet G, Heppelmann B, Klusch A, Kniffki KD: Plasticity in the expression of bradykinin binding sites in sensory neurons after mechanical nerve injury. Neuroscience. 1998, 83: 949-959. 10.1016/S0306-4522(97)00465-X.
Eckert A, Segond von Banchet G, Sopper S, Petersen M: Spatio-temporal pattern of induction of bradykinin receptors and inflammation in rat dorsal root ganglia after unilateral nerve ligation. Pain. 1999, 83: 487-497. 10.1016/S0304-3959(99)00152-9.
von Banchet SG, Kiehl M, Schaible HG: Acute and long-term effects of IL-6 on cultured dorsal root ganglion neurones from adult rat. J Neurochem. 2005, 94: 238-248. 10.1111/j.1471-4159.2005.03185.x.
Mentzel K, Bräuer R: Matrix metalloproteinases, IL-6, and nitric oxide in rat antigen-induced arthritis. Clin Exp Rheumatol. 1998, 16: 269-276.
Vega JA, Rodriguez C, Medina M, del Valle ME: Neuron-specific enolase (NSE)-like and neurofilament protein (NFP)-like immunoreactivities in the rat dorsal root ganglia and sciatic nerve. Cell Mol Biol. 1990, 36: 537-546.
Greffrath W, Binzen U, Schwarz ST, Saaler-Reinhardt S, Treede RD: Co-expression of heat sensitive vanilloid receptor subunits in rat dorsal root ganglion neurones. Neuroreport. 2003, 14: 2251-2255. 10.1097/00001756-200312020-00023.
Ahluwalia J, Rang H, Nagy I: The putative role of vanilloid receptor-like protein-1 in mediating high threshold noxious heat-sensitivity in rat cultured primary sensory neurons. Eur J Neurosci. 2002, 16: 1483-1489. 10.1046/j.1460-9568.2002.02231.x.
Anand U, Otto WR, Casula MA, Day NC, Davis JB, Bountra R, Anand P: The effect of neurotrophic factors on morphology, TRPV1 expression and capsaicin responses of cultured human DRG sensory neurones. Neurosci Lett. 2006, 399: 51-56. 10.1016/j.neulet.2006.01.046.
Senba E, Katanosaka K, Yajima H, Mizumura K: The immunosuppressant FK506 activates capsaicin- and bradykinin-sensitive DRG neurons and cutaneous C-fibers. Neurosci Res. 2004, 50: 257-262. 10.1016/j.neures.2004.07.005.
The authors thank Antje Wallner and Renate Stöckigt for excellent technical assistance. The study was supported by the Interdisziplinäres Zentrum für Klinische Forschung (IZKF) at the University of Jena.
The authors declare that they have no competing interests.
GSvB and JR produced cultures of DRG neurones and established the co-culture system. They also carried out the labelling of neurones. MH, CR and RB induced the antigen-induced arthritis and produced the cultures of FLS cells, carried out the ELISA study and collaborated in establishing the co-culture system. HGS was involved in planning the study and the preparation of the manuscript.
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
About this article
Cite this article
von Banchet, G.S., Richter, J., Hückel, M. et al. Fibroblast-like synovial cells from normal and inflamed knee joints differently affect the expression of pain-related receptors in sensory neurones: a co-culture study . Arthritis Res Ther 9, R6 (2007). https://doi.org/10.1186/ar2112
- Dorsal Root Ganglion
- Dorsal Root Ganglion Neurone
- Inflame Joint
- TRPV1 Receptor
- Culture Dorsal Root Ganglion Neurone